{{Rsnum
|rsid=2126709
|Gene=ZNF202
|Chromosome=11
|position=123725219
|Orientation=plus
|GMAF=0.07025
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ZNF202
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 99.1 | 0.9 | 0.0
| HCB | 65.0 | 32.1 | 2.9
| JPT | 82.3 | 15.9 | 1.8
| YRI | 95.9 | 4.1 | 0.0
| ASW | 96.4 | 3.6 | 0.0
| CHB | 65.0 | 32.1 | 2.9
| CHD | 69.7 | 27.5 | 2.8
| GIH | 99.0 | 1.0 | 0.0
| LWK | 93.6 | 6.4 | 0.0
| MEX | 69.0 | 29.3 | 1.7
| MKK | 97.4 | 2.6 | 0.0
| TSI | 96.1 | 3.9 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19875103
|Trait=Response to antipsychotic therapy (extrapyramidal side effects)
|Title=Genomewide Association Study of Movement-Related Adverse Antipsychotic Effects
|RiskAllele=
|Pval=4E-7
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PMID|21162693|OA=1
}} Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2126709
|overall_frequency_n=6
|overall_frequency_d=128
|overall_frequency=0.046875
|n_genomes=5
|n_genomes_annotated=0
|n_haplomes=6
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}